Provide Input on Clinical Research Infrastructure and Emergency Clinical Trials

Funding News Edition:
See more articles in this edition

The White House Office of Science and Technology Policy (OSTP) and National Security Council (NSC) recently released a request for information (RFI) seeking community feedback on how to strengthen the capacity of clinical trial infrastructure and emergency trials. NIH Deputy Director for Extramural Research Dr. Michael Lauer added context to the RFI in his article “Feedback Sought on Strengthening Capacity for Emergency Clinical Trials.”

Below are some areas of interest from the RFI. Specifically, OSTP is interested in hearing from all stakeholders on what strategies worked and didn’t work during the COVID-19 pandemic, and how we can apply these lessons learned moving forward:

  • What do institutions and scientists need to keep the research base warm and ready for action?
  • How can we get the enterprise rowing in the same direction from day one, asking the right scientific questions, and efficiently coordinating resources?
  • How do we ensure that all Americans and all communities can participate in high-quality, impactful clinical research studies?
  • How can we make sure this is organized and governed appropriately, across public and private sectors?
  • What opportunities are available to make advance agreements to streamline the research response in real time?

If you want to provide input, send comments to by 5 p.m. Eastern Time on December 27, 2022, and include “Emergency Clinical Trials RFI” in the subject line.

Contact Us

Email us at for help navigating NIAID’s grant and contract policies and procedures.

Content last reviewed on